Article de revue
Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka
To facilitate introduction of live attenuated SA 14-14-2 Japanese encephalitis vaccine (LJEV) into the National Immunization Programme of Sri Lanka, we evaluated the safety and immunogenicity of co-administration of LJEV and measles vaccine at 9 months of age. Serum immune responses were evaluated post-vaccination on days 28, 180, and 365 using JE neutralization test and anti-measles IgG ELISA.
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
Vaccine
Volume
37
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Encéphalite japonaise
Pays
- Sri Lanka
Mots-clés
- AEFI
Régions de l'OMS
- Région de l'Asie du Sud-Est